Piperine improves levodopa availability in the 6-OHDA-lesioned rat model of Parkinson's disease by suppressing gut bacterial tyrosine decarboxylase.
Xiaolu HuLan YuYatong LiXiaoxi LiYimeng ZhaoLijuan XiongJiaxuan AiQijun ChenXing WangXiaoqing ChenYinying BaYaonan WangXia WuPublished in: CNS neuroscience & therapeutics (2023)
Oral administration of L-dopa combined with PIP can improve L-dopa availability and brain DA level in 6-OHDA-lesioned rats by suppressing intestinal bacterial TDC.